Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$106.13 - $120.89 $3.29 Million - $3.75 Million
31,000 Added 14.91%
238,900 $27.5 Million
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $19.2 Million - $22.3 Million
207,900 New
207,900 $22.1 Million
Q1 2022

May 11, 2022

BUY
$80.11 - $90.62 $2.77 Million - $3.14 Million
34,600 Added 37.12%
127,800 $11.2 Million
Q4 2021

Feb 10, 2022

SELL
$79.7 - $88.13 $12.6 Million - $14 Million
-158,500 Reduced 62.97%
93,200 $8.15 Million
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $1.09 Million - $1.32 Million
-14,000 Reduced 5.27%
251,700 $23.8 Million
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $829,614 - $919,100
-10,100 Reduced 3.66%
265,700 $23.1 Million
Q2 2020

Aug 12, 2020

BUY
$80.93 - $91.1 $17.2 Million - $19.3 Million
212,000 Added 332.29%
275,800 $24.1 Million
Q1 2020

May 13, 2020

BUY
$70.67 - $99.01 $1.65 Million - $2.32 Million
23,400 Added 57.92%
63,800 $5.26 Million
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $3.41 Million - $3.85 Million
40,400 New
40,400 $3.83 Million
Q2 2018

Aug 08, 2018

SELL
$64.91 - $73.36 $8.16 Million - $9.22 Million
-125,700 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$70.39 - $84.15 $380,106 - $454,410
5,400 Added 4.49%
125,700 $10.2 Million
Q4 2017

Feb 09, 2018

BUY
$72.33 - $77.64 $7.59 Million - $8.14 Million
104,900 Added 681.17%
120,300 $10.1 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $1.14 Million - $1.19 Million
15,400
15,400 $1.32 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.